Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sphere of biopharmaceuticals, featuring promising enhancements across different medical and industrial programs. With its structural similarity to In a natural way derived human serum albumin, OsrHSA presents a safer, much more responsible substitute for therape